September 1, 2026Stocks·Bullish·pharma
Novartis shares rise on positive Phase III MS trial results
Novartis shares rose over 4.5% after the company reported positive results in two late-stage Phase III trials of its new pill for the most common form of multiple sclerosis.
Detected & updated continuously · Source: Nebula
Story subjects
Sources
@robertojirusta
Novartis climbs 4.5% on positive drug trial https://t.co/OZQcnVoNCl Las acciones de la corporación farmacéutica suiza Novartis AG subieron más de un 4,5% el martes, después de que la compañía reportara resultados positivos en el ensayo de #fase III de su fármaco candidato para
@WSJ
Novartis shares rose after the drugmaker reported positive results in two late-stage trials from its new pill for the most common form of multiple sclerosis. https://t.co/gF9KNBgKOr